Serum and synovial fluid hydroxyproline fractions in microcrystalline arthritis and osteoarthritis.
Synovial fluid and serum hydroxyproline fractions were investigated in patients with osteoarthritis and microcrystalline arthritis. Synovial fluid dialysable hydroxyproline levels are higher than serum levels in both conditions. Synovial fluid total and dialysable hydroxyproline are higher in microcrystalline arthritis than in osteoarthritis, while non-dialysable hydroxyproline values are similar in both conditions. In microcrystalline arthritis, synovial fluid dialysable hydroxyproline and polymorphonuclear leukocyte counts closely parallel each other. Irrespective of the type of arthropathy, synovial fluid dialysable hydroxyproline levels correlate with urinary hydroxyproline excretion. While the data suggest overproduction of dialysable hydroxyproline by joints in both conditions, the overproduction appears to be mediated by polymorphonuclear leukocytes in microcrystalline arthritis only. The ratio of serum to synovial total hydroxyproline are further suggestive of a possible differentiation between osteoarthritis and microcrystalline arthritis. In the conditions governing the present study, urinary hydroxyproline may be used as an index of joint tissue collagen resorption. Finally the significance of synovial fluid and serum non-dialysable hydroxyproline is discussed.
D002805:Chondrocalcinosis / Q000097:blood / Q000378:metabolism*; D006073:Gout / Q000097:blood / Q000378:metabolism*; D006801:Humans; D006909:Hydroxyproline / Q000032:analysis* / Q000097:blood / Q000652:urine; D007958:Leukocyte Count; D009504:Neutrophils; D010003:Osteoarthritis / Q000097:blood / Q000378:metabolism*; D013582:Synovial Fluid / Q000032:analysis*
D006909:Hydroxyproline